Drugs / DTPa-HBV-IPV
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01457508 Comparator | Jan 1999 → Mar 2000 | diphtheria, hepatitis B virus infection, pertussis, poliomyelitis +1 | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTPa-HBV-IPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01457508 ↗ |
| Modality | Vaccine | “DTPa-HBV-IPV (Infanrix penta™) and Hib (Hiberix™) vaccine” NCT01457508 ↗ |